Global Pimozide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
According to our (Global Info Research) latest study, the global Pimozide market size was valued at USD 11 million in 2022 and is forecast to a readjusted size of USD 11 million by 2029 with a CAGR of -0.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent. 
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
This report is a detailed and comprehensive analysis for global Pimozide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pimozide market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pimozide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pimozide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pimozide market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pimozide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pimozide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Par Pharmaceutical, Johnson & Johnson, Eumedica and Pharmascience, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Pimozide market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    1Mg
    2Mg
    4Mg
Market segment by Application
    Hospitals
    Drugstores
    Others
Major players covered
    Teva
    Par Pharmaceutical
    Johnson & Johnson
    Eumedica
    Pharmascience
    Domina Pharmaceuticals
    Aa Pharma
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pimozide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pimozide, with price, sales, revenue and global market share of Pimozide from 2018 to 2023.
Chapter 3, the Pimozide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pimozide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pimozide market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pimozide.
Chapter 14 and 15, to describe Pimozide sales channel, distributors, customers, research findings and conclusion.